Are two medicines instead of three the future of HIV tr...

The era of exclusive triple therapy for the treatment of HIV may be coming to an end as evidence mounts in support of the safety and efficacy of new dual-therapy (two-drug) regimens. The era of exclusive triple therapy for the treatment of HIV may be coming to an end as evidence mounts in suppo...

Related Keywords

South Africa ,United States ,Argentina ,South African ,Michelle Moorhouse ,Francois Venter ,Andesand Gardel ,Pedro Cahn ,Department Of Health ,Human Services ,African Health Products Regulatory Authority ,Clinical Society ,University Of The Witwatersrand ,Clinicians Society ,Huesped Foundation ,Viiv Healthcare ,Phase Three ,Infectious Diseases ,Nucleoside Reverse Transcriptase Inhibitor ,United States Food ,Drug Administration ,South African Health Products Regulatory ,Professor Francois Venter ,Viral Hepatitis ,